{"title":"通过多孔光固化水凝胶局部递送培养的角膜缘干细胞:一种无创、方便、高效的角膜缘干细胞缺乏干细胞递送策略","authors":"Shujia Guo, Yi Han, Jiani Li, Yuhan Huang, Dong Yu, Yuwen Liu, Yuqian Wang, Chaoyu Fan, Yimin Huang, Wenyin Guan, Danyi Qin, Lan Zheng, Caihong Huang, Cheng Li, Jiaoyue Hu, Zuguo Liu","doi":"10.1016/j.jconrel.2025.113900","DOIUrl":null,"url":null,"abstract":"Topical administration of stem cells is one of the simplest approaches to stem cell-based therapy for limbal stem cell deficiency (LSCD). Without timely supplementation of deficient stem cells, LSCD may worsen, carrying a high risk of blindness in severe cases. However, challenges such as stem cell loss, poor cell attachment, short retention time, and phenotypic transformation of stem cells limit the efficiency of direct stem cell delivery. To address these problems, this study conducted <em>in vitro</em> and <em>in vivo</em> screenings of photocurable hydrogels and identified a porous Gelatin Methacryloyl (PG) hydrogel with larger pore sizes prepared by phase separation technology that satisfies four critical conditions: (i) encapsulating stem cells before delivery, (ii) maintaining the viability and self-renewal of stem cells <em>via</em> activation of the non-canonical Wnt signaling pathway, (iii) adhering uniformly to the ocular surface, and (iv) supporting stem cell proliferation, migration, and adhesion to the target interfaces. In a rabbit model of LSCD, the PG hydrogel loaded with cultivated limbal stem cells was applied to the ocular surface in combination with corneal bandage lenses, enabling a sutureless, non-invasive, convenient, and efficient stem cell delivery system. This innovative delivery strategy not only greatly simplified the existing process of limbal stem cell transplantation and significantly reduced surgery time, but also successfully overcame the challenges associated with direct stem cell eye drops. Most importantly, it promoted corneal injury repair, achieving avascular and scar-free corneal regeneration.","PeriodicalId":15450,"journal":{"name":"Journal of Controlled Release","volume":"58 1","pages":""},"PeriodicalIF":10.5000,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Topical delivery of cultivated limbal stem cells via porous photocurable hydrogel: A noninvasive, convenient, and efficient stem cells delivery strategy for limbal stem cell deficiency\",\"authors\":\"Shujia Guo, Yi Han, Jiani Li, Yuhan Huang, Dong Yu, Yuwen Liu, Yuqian Wang, Chaoyu Fan, Yimin Huang, Wenyin Guan, Danyi Qin, Lan Zheng, Caihong Huang, Cheng Li, Jiaoyue Hu, Zuguo Liu\",\"doi\":\"10.1016/j.jconrel.2025.113900\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Topical administration of stem cells is one of the simplest approaches to stem cell-based therapy for limbal stem cell deficiency (LSCD). Without timely supplementation of deficient stem cells, LSCD may worsen, carrying a high risk of blindness in severe cases. However, challenges such as stem cell loss, poor cell attachment, short retention time, and phenotypic transformation of stem cells limit the efficiency of direct stem cell delivery. To address these problems, this study conducted <em>in vitro</em> and <em>in vivo</em> screenings of photocurable hydrogels and identified a porous Gelatin Methacryloyl (PG) hydrogel with larger pore sizes prepared by phase separation technology that satisfies four critical conditions: (i) encapsulating stem cells before delivery, (ii) maintaining the viability and self-renewal of stem cells <em>via</em> activation of the non-canonical Wnt signaling pathway, (iii) adhering uniformly to the ocular surface, and (iv) supporting stem cell proliferation, migration, and adhesion to the target interfaces. In a rabbit model of LSCD, the PG hydrogel loaded with cultivated limbal stem cells was applied to the ocular surface in combination with corneal bandage lenses, enabling a sutureless, non-invasive, convenient, and efficient stem cell delivery system. This innovative delivery strategy not only greatly simplified the existing process of limbal stem cell transplantation and significantly reduced surgery time, but also successfully overcame the challenges associated with direct stem cell eye drops. Most importantly, it promoted corneal injury repair, achieving avascular and scar-free corneal regeneration.\",\"PeriodicalId\":15450,\"journal\":{\"name\":\"Journal of Controlled Release\",\"volume\":\"58 1\",\"pages\":\"\"},\"PeriodicalIF\":10.5000,\"publicationDate\":\"2025-05-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Controlled Release\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jconrel.2025.113900\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Controlled Release","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jconrel.2025.113900","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
Topical delivery of cultivated limbal stem cells via porous photocurable hydrogel: A noninvasive, convenient, and efficient stem cells delivery strategy for limbal stem cell deficiency
Topical administration of stem cells is one of the simplest approaches to stem cell-based therapy for limbal stem cell deficiency (LSCD). Without timely supplementation of deficient stem cells, LSCD may worsen, carrying a high risk of blindness in severe cases. However, challenges such as stem cell loss, poor cell attachment, short retention time, and phenotypic transformation of stem cells limit the efficiency of direct stem cell delivery. To address these problems, this study conducted in vitro and in vivo screenings of photocurable hydrogels and identified a porous Gelatin Methacryloyl (PG) hydrogel with larger pore sizes prepared by phase separation technology that satisfies four critical conditions: (i) encapsulating stem cells before delivery, (ii) maintaining the viability and self-renewal of stem cells via activation of the non-canonical Wnt signaling pathway, (iii) adhering uniformly to the ocular surface, and (iv) supporting stem cell proliferation, migration, and adhesion to the target interfaces. In a rabbit model of LSCD, the PG hydrogel loaded with cultivated limbal stem cells was applied to the ocular surface in combination with corneal bandage lenses, enabling a sutureless, non-invasive, convenient, and efficient stem cell delivery system. This innovative delivery strategy not only greatly simplified the existing process of limbal stem cell transplantation and significantly reduced surgery time, but also successfully overcame the challenges associated with direct stem cell eye drops. Most importantly, it promoted corneal injury repair, achieving avascular and scar-free corneal regeneration.
期刊介绍:
The Journal of Controlled Release (JCR) proudly serves as the Official Journal of the Controlled Release Society and the Japan Society of Drug Delivery System.
Dedicated to the broad field of delivery science and technology, JCR publishes high-quality research articles covering drug delivery systems and all facets of formulations. This includes the physicochemical and biological properties of drugs, design and characterization of dosage forms, release mechanisms, in vivo testing, and formulation research and development across pharmaceutical, diagnostic, agricultural, environmental, cosmetic, and food industries.
Priority is given to manuscripts that contribute to the fundamental understanding of principles or demonstrate the advantages of novel technologies in terms of safety and efficacy over current clinical standards. JCR strives to be a leading platform for advancements in delivery science and technology.